Terms: = Cervical cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
10 results:
1. Efficacy of photodynamic therapy in women with HSIL, LSIL and early stage squamous cervical cancer: a systematic review and meta-analysis.
Unanyan A; Pivazyan L; Davydova J; Murvatova K; Khrapkova A; Movsisyan R; Ishchenko A; Ishchenko A
Photodiagnosis Photodyn Ther; 2021 Dec; 36():102530. PubMed ID: 34534688
[TBL] [Abstract] [Full Text] [Related]
2. Knowledge and Attitude Toward Human Papillomavirus Infection and Vaccination among Thai Women: A Nationwide Social Media Survey.
Likitdee N; Kietpeerakool C; Chumworathayi B; Temtanakitpaisan A; Aue-Aungkul A; Nhokaew W; Jampathong N
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2895-2902. PubMed ID: 33112546
[TBL] [Abstract] [Full Text] [Related]
3. Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer.
Chay DB; Han GH; Nam S; Cho H; Chung JY; Hewitt SM
Int J Clin Oncol; 2019 Nov; 24(11):1429-1439. PubMed ID: 31302815
[TBL] [Abstract] [Full Text] [Related]
4. Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.
Lee JH; Lee SW; Kim JR; Kim YS; Yoon MS; Jeong S; Kim JH; Lee JY; Eom KY; Jeong BK; Lee SH
Gynecol Oncol; 2017 Dec; 147(3):577-584. PubMed ID: 29110878
[TBL] [Abstract] [Full Text] [Related]
5. GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal cervical Cytology: Results of a Phase I Clinical Trial.
Van Damme P; Bouillette-Marussig M; Hens A; De Coster I; Depuydt C; Goubier A; Van Tendeloo V; Cools N; Goossens H; Hercend T; Timmerman B; Bissery MC
Clin Cancer Res; 2016 Jul; 22(13):3238-48. PubMed ID: 27252412
[TBL] [Abstract] [Full Text] [Related]
6. Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors.
Von Hoff DD; Mita MM; Ramanathan RK; Weiss GJ; Mita AC; LoRusso PM; Burris HA; Hart LL; Low SC; Parsons DM; Zale SE; Summa JM; Youssoufian H; Sachdev JC
Clin Cancer Res; 2016 Jul; 22(13):3157-63. PubMed ID: 26847057
[TBL] [Abstract] [Full Text] [Related]
7. Cost-Effectiveness of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications.
Marino P; Houvenaeghel G; Narducci F; Boyer-Chammard A; Ferron G; Uzan C; Bats AS; Mathevet P; Dessogne P; Guyon F; Rouanet P; Jaffre I; Carcopino X; Perez T; Lambaudie E
Int J Gynecol Cancer; 2015 Jul; 25(6):1102-8. PubMed ID: 26098092
[TBL] [Abstract] [Full Text] [Related]
8. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology.
Sharp L; Cotton S; Thornton A; Gray N; Cruickshank M; Whynes D; Duncan I; Hammond R; Smart L; Little J
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):318-25. PubMed ID: 22921577
[TBL] [Abstract] [Full Text] [Related]
9. Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.
Feng Q; Wei H; Morihara J; Stern J; Yu M; Kiviat N; Hellstrom I; Hellstrom KE
Gynecol Oncol; 2012 Nov; 127(2):412-9. PubMed ID: 22828962
[TBL] [Abstract] [Full Text] [Related]
10. Variable risk of cervical precancer and cancer after a human papillomavirus-positive test.
Castle PE; Fetterman B; Poitras N; Lorey T; Shaber R; Schiffman M; Demuth F; Kinney W
Obstet Gynecol; 2011 Mar; 117(3):650-656. PubMed ID: 21343769
[TBL] [Abstract] [Full Text] [Related]
